Image-guided cancer treatment using biocompatible copper-based nanomaterials

Announcing a new article publication for BIO Integration journal. Cancer is a significant disease that poses a major threat to human health.

Relief Therapeutics Announces Filing of Form 15F to Terminate SEC Reporting Obligations – Biotech Investments

Relief Therapeutics Holding SA / Key word(s): Miscellaneous 13-Dec-2024 / 23:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

December 15, 2024

Cybin Announces Unprecedented Positive Phase 2 Interim Data for CYB003 in Major Depressive Disorder Meeting Primary Efficacy Endpoint with Rapid and Significant Improvements in Depression Symptoms After Single Dose | Psychedelic Invest

–interim readout shows rapid, robust, and clinically significant reduction of depression symptoms three weeks after a single 12mg dose, with an unprecedented mean -14 point

November 1, 2023

Adding Nurse Care Managers in Primary Care Boosted OUD Treatment

Integrating nurse care managers into primary care teams significantly increased access to opioid use disorder (OUD) treatment compared with usual care, a cluster randomized trial

November 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.